Myocardial substrate metabolism in obesity.

Myocardial substrate metabolism in obesity.

Veure altres versions (1)

Obesity is linked to a wide variety of cardiac changes, from subclinical diastolic dysfunction to end-stage systolic heart failure. Obesity causes changes in cardiac metabolism, which make ATP production and utilization less efficient, producing functional consequences that are linked to the increas...

Descripció completa

Dades bibliogràfiques
Autors principals:	Rider, O, Cox, P, Tyler, D, Clarke, K, Neubauer, S
Format:	Journal article
Idioma:	English
Publicat:	2013

Ítems similars

Myocardial substrate metabolism in obesity
per: Rider, O, et al.
Publicat: (2012)

The Effects of Catecholamine Stress and Weight Loss on Myocardial Relaxation and High Energy Phosphate Metabolism in Obesity
per: Rider, O, et al.
Publicat: (2009)

Effects of weight loss on myocardial energetics and diastolic function in obesity
per: Rider, O, et al.
Publicat: (2013)

Effects of weight loss on myocardial energetics and diastolic function in obesity.
per: Rider, O, et al.
Publicat: (2013)

The Effect of Catecholamine Stress on Myocardial Relaxation in Obese Subjects
per: Rider, O, et al.
Publicat: (2008)

Effects of catecholamine stress on diastolic function and myocardial energetics in obesity
per: Rider, O, et al.
Publicat: (2012)

Effects of catecholamine stress on diastolic function and myocardial energetics in obesity.
per: Rider, O, et al.
Publicat: (2012)

Effects of Catecholamine Stress on Diastolic Function and Myocardial Energetics in Obesity
per: Rider, O, et al.
Publicat: (2012)

Myocardial substrate metabolism in heart disease.
per: Evans, R, et al.
Publicat: (2012)

Structural and Metabolic Effects of Obesity on the Myocardium and the Aorta.
per: Rider, O, et al.
Publicat: (2014)

Myocardial tissue phase mapping reveals impaired myocardial tissue velocities in obesity.
per: Rider, O, et al.
Publicat: (2015)

Myocardial tissue phase mapping reveals impaired myocardial tissue velocities in obesity
per: Rider, O, et al.
Publicat: (2014)

Pyruvate dehydrogenase as a therapeutic target for obesity cardiomyopathy
per: Lewis, A, et al.
Publicat: (2016)

Myocardial energetics in obesity: Enhanced ATP delivery through creatine kinase with blunted stress response
per: Rayner, JJ, et al.
Publicat: (2020)

Hyperpolarized 13 C and 31 P MRS detects differences in cardiac energetics, metabolism, and function in obesity, and responses following treatment
per: Lewis, AJM, et al.
Publicat: (2024)

Structural and Metabolic Effects of Obesity on the Myocardium and the Aorta
per: Oliver J. Rider, et al.
Publicat: (2014-10-01)

Letter by Rider and Neubauer regarding article, "Cardiac remodeling in obesity".
per: Rider, O, et al.
Publicat: (2013)

Nicotinic acid receptor agonists impair myocardial contractility by energy starvation
per: Watson, WD, et al.
Publicat: (2020)

Obesity modifies the energetic phenotype in dilated cardiomyopathy
per: Rayner, JJ, et al.
Publicat: (2021)

Proof-of-principle demonstration of direct metabolic imaging following myocardial infarction using hyperpolarized 13C CMR
per: Apps, A, et al.
Publicat: (2021)

The relative contribution of metabolic and structural abnormalities to diastolic dysfunction in obesity
per: Rayner, J, et al.
Publicat: (2017)

Increasing plasma free fatty acids in healthy subjects induces aortic distensibility changes seen in obesity.
per: Rider, O, et al.
Publicat: (2012)

Hyperpolarised magnetic resonance for in vivo real-time metabolic imaging
per: Apps, A, et al.
Publicat: (2018)

The effect of hyperpolarized tracer concentration on myocardial uptake and metabolism.
per: Schroeder, M, et al.
Publicat: (2009)

Development of dynamic nuclear polarization techniques to measure substrate metabolism and uptake in the heart
per: Schroeder, M, et al.
Publicat: (2006)

Determinants of left ventricular mass in obesity; a cardiovascular magnetic resonance study.
per: Rider, O, et al.
Publicat: (2009)

Cardiac metabolic manipulation alters cardiac energetics and function
per: Watson, W, et al.
Publicat: (2020)

Obesity and the heart: cardiovascular magnetic resonance imaging evidence of the beneficial effects of bariatric surgery.
per: Rider, O, et al.
Publicat: (2012)

Concentric left ventricular remodeling and aortic stiffness: a comparison of obesity and hypertension.
per: Rider, O, et al.
Publicat: (2013)

Concentric left ventricular remodeling and aortic stiffness: A comparison of obesity and hypertension
per: Rider, O, et al.
Publicat: (2013)

Myocardial Metabolism in Heart Failure with Preserved Ejection Fraction
per: Henry, JA, et al.
Publicat: (2024)

Evidence of a direct effect of myocardial dteatosis on LV hypertrophy and diastolic dysfunction in adult and adolescent obesity
per: Banerjee, R, et al.
Publicat: (2015)

Uncomplicated obesity is characterised by altered systolic and diastolic myocardial velocities as assessed by phase contrast magnetic resonance imaging
per: Ali, M, et al.
Publicat: (2007)

Modification of myocardial substrate use as a therapy for heart failure.
per: Abozguia, K, et al.
Publicat: (2006)

The effects of energetic substrate manipulation on myocardial metabolism and cardiac function
per: Watson, WD
Publicat: (2021)

Ventricular hypertrophy and cavity dilatation in relation to body mass index in women with uncomplicated obesity.
per: Rider, O, et al.
Publicat: (2011)

The effect of obesity and weight loss on aortic pulse wave velocity as assessed by magnetic resonance imaging
per: Rider, O, et al.
Publicat: (2010)

The effect of obesity and weight loss on aortic pulse wave velocity as assessed by magnetic resonance imaging.
per: Rider, O, et al.
Publicat: (2010)

Insights into the metabolic aspects of aortic stenosis with the use of magnetic resonance imaging
per: Monga, S, et al.
Publicat: (2022)

The effect of dobutamine stress on diastolic filling rates in obese subjects
per: Clarke Kieran, et al.
Publicat: (2009-01-01)